tirzepatide taken off market Experts warn about dangers of black weight loss meds FDA says shortage of GLP-1

The trials also revealed that patients lost an average of 18-20% of their body weight over 52 weeks, easing pressure on the airway and improving breathing patterns

These products are not considered safe for consumer use, as their purity, sterility, dosing accuracy, storage conditions, and ingredient authenticity cannot be verified

For drugs with short half-lives, poor compliance with prescribed treatment regimens reduces plasma concentrations to unsuitable levels, and multiple doses are often required to return to therapeutic plasma concentrations

Some people may feel appetite suppression most strongly in the first couple of days after an injection, but the effect generally holds across the week

#DigitalHealth #LabReports #AIinHealthcare #FutureOfCare #NextcareLife To view or add a comment, sign in Where Are Your Patients Really